Medmate Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 17 Year, 24 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 Cr
- Revenue Growth 24.23%
- Profit Growth -5.69%
- Ebitda -78.82%
- Net Worth 13.06%
- Total Assets -9.00%
About Medmate Pharma
Medmate Pharma Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 January 2008 and has a history of 17 years. Its registered office is in Ernakulam, Kerala, India.
The Corporate was formerly known as Getwell Enterprises Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹7.50 Cr.
Dimple Kumar, Dileepkumar Nair, Kariyadath Shaji, and One other member serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239KL2008PTC021657
-
Company No.
021657
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jan 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
What products or services does Medmate Pharma Private Limited offer?
Medmate Pharma Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Medmate Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padma Karunakaran
|
Managing Director | 08-Jan-2008 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Dileepkumar Nair
|
Director | 01-Oct-2009 | Current |
|
Dimple Kumar
|
Director | 08-Jan-2008 | Current |
|
Kariyadath Shaji
|
Director | 27-Apr-2019 | Current |
Financial Performance of Medmate Pharma.
Medmate Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.23% increase. The company also saw a slight decrease in profitability, with a 5.69% decrease in profit. The company's net worth Soared by an impressive increase of 13.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medmate Pharma?
In 2023, Medmate Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cv Projects Private LimitedDimple Kumar and Padma Karunakaran are mutual person
-
Irid Biocare LlpPadma Karunakaran is a mutual person
Charges (Loans)
₹75.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 6.50 Cr
- The Federal Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2018 | Others | ₹5.00 M | Open |
| 07 Dec 2018 | Others | ₹2.50 Cr | Open |
| 15 Feb 2016 | Others | ₹2.50 Cr | Open |
| 10 Dec 2015 | Others | ₹1.00 Cr | Open |
| 20 Feb 2009 | The Federal Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Medmate Pharma?
Medmate Pharma has a workforce of 18 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medmate Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medmate Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
